Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer

Completed

Looking for future studies?

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Sex eligibility

Male

Study type

Observational

Primary location

Research Site, Acquaviva delle Fonti, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

non metastatic Prostate Cancer
previous treatment with bicalutamide 150mg
biochemical relapse/progression

Exclusion criteria

use of other treatments for Prostate Cancer

Treatment and study plan

Primary outcomes

Hormonal sensitivity to second line treatment for CaP after Bicalutamide

Time frame: six months

Secondary outcomes

median duration of second and third line treatments;

Time frame: six months

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients

Acronym: Sorse

Important dates

Study start: 2007
Primary completion: 2007
Study completion: 2008
First posted: Apr 28, 2008
Registry last updated: Dec 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed